PP_FloatingRateCapitalLtd_RGB copy.jpg
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
February 05, 2025 16:05 ET | PennantPark Floating Rate Capital Ltd.
MIAMI, Feb. 05, 2025 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) declares its monthly distribution for February 2025 of $0.1025 per share, payable on...
Allot to Release Fou
Allot to Release Fourth Quarter & Full Year 2024 Results and Host Conference Call on February 25, 2025
February 05, 2025 09:08 ET | Allot
Hod Hasharon, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative network-native cybersecurity and network intelligence solutions...
Can-Fite BioPharma Logo.jpg
Can-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025
February 05, 2025 07:00 ET | Can-Fite BioPharma Ltd.
Ramat Gan, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...
logo
SaverOne Announces New Deployment of Its Driver Distraction Prevention System in Teva Pharmaceutical’s Truck Fleet
February 04, 2025 09:12 ET | SaverOne 2014 Ltd.
Teva, a global pharmaceutical leader, to install the SaverOne System across its entire fleet of 50 delivery trucks in Israel Petah Tikvah, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014...
pluri.jpg
Pluri Secures Additional $3.5 Million Investment from Major Shareholder at Premium to Market, Bringing Total Recent Financings to $10 Million
February 04, 2025 07:00 ET | Pluri Inc.
New investment follows recent private placement of $6.5 million with global investor and entrepreneur, Mr. Alejandro WeinsteinFunds are intended to support Pluri’s growth and execution strategy as a...
purple-logo2020.png
Purple Biotech Announces Research Collaboration with the Icahn School of Medicine at Mount Sinai for CAPTN-3 Tri-Specific Antibody Platform
February 03, 2025 07:00 ET | Purple Biotech Ltd.
Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing tumor-specific immunity against multiple cancer...
image001-2.png
Enlight to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 19, 2025
January 30, 2025 13:30 ET | Enlight Renewable Energy Ltd.
TEL AVIV, Israel, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Enlight Renewable Energy Ltd. (“Enlight”, “the Company”, NASDAQ: ENLT, TASE: ENLT.TA), a leading global renewable energy platform, today announced...
logo
SaverOne Announces $1.5 Million Registered Direct Offering
January 30, 2025 09:09 ET | SaverOne 2014 Ltd.
Petah Tikvah, Israel, Jan. 30, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology leader in advanced transportation safety solutions, today announced that it has...
logo
SaverOne to Deploy Driver Safety Systems Across Oz Group’s Fleet
January 30, 2025 09:00 ET | SaverOne 2014 Ltd.
100 SaverOne Systems will be installed in Oz Group Trucks and Cars Petah Tikvah, Israel, Jan. 30, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a leading innovator in...
teva_RGB_JPEG.jpg
Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth
January 29, 2025 07:00 ET | Teva Pharmaceutical Industries Ltd
2024 Revenues of $16.5 billion reflect an increase of 6%, in local currency terms, compared to 2023;AUSTEDO® - exceeding $1.6 billion in revenues, surpassing 2024 outlook;AJOVY® - global annual...